In episode 4 of the podcast pharmaphorum talked to Dr Joe Wiley, CEO of UK-based biopharmaceutical company Amryt Pharma, about its strategy and work in the rare diseases and gene therapy space.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
